SCHEMBL5440915

SCHEMBL5440915

N#Cc1ccc(N(C(=O)c2cc3cc([N+](=O)[O-])ccc3s2)n2ccnc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
HPGD P15428 1/20 0.48
CYP2C19 P33261 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.42
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 3/20 0.41
POLB P06746 3/20 0.41
ALDH1A1 P00352 2/20 0.41
GAA P10253 2/20 0.40
CLK1 P49759 1/20 0.37
MAPT P10636 2/20 0.37
CYP19A1 P11511 2/20 0.36
TBXAS1 P24557 2/20 0.36
ABCG2 Q9UNQ0 1/20 0.34
MEN1 O00255 2/20 0.34
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5440775 0.87 CLK1 (0.39) CYP2C19LMNACLK1CYP19A1TBXAS1
SCHEMBL5440768 0.81 CA1 (0.39) KMT2ACYP2C19CLK1MAPTCYP19A1
SCHEMBL5442082 0.73 CYP19A1 (0.43) KMT2ANPC1MAPTCYP19A1MEN1
SCHEMBL5998477 0.70 KMT2A (0.43) KMT2ASMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL6233545 0.67 KMT2A (0.73) KMT2ACYP1A2CYP2C9HPGDCYP2C19
SCHEMBL5988376 0.66 MAPT (0.39) KMT2AMAPTCYP19A1ABCG2MEN1
SCHEMBL5445776 0.66 CYP19A1 (0.47) CYP19A1
SCHEMBL5435456 0.66 MEN1 (0.41) KMT2ASMN1; SMN2RAB9ALMNAALDH1A1
SCHEMBL5439326 0.65 SMN1; SMN2 (0.62) KMT2ACYP1A2CYP2C9HPGDCYP2C19
SCHEMBL1491507 0.64 POLB (0.63) KMT2ACYP1A2CYP2C9HPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476455-B2 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2013-07-02 US disclosed
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2007-05-17 US disclosed
EP-1694650-A1 1-N-PHENYL-AMINO-1H-IMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LABORATOIRE THERAMEX (MC) 2006-08-30 EP disclosed
WO-2005058842-A1 1-N-PHENYL-AMINO-1H-IMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LABORATOIRE THERAMEX (MC) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them H1-0, H1-5, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 KMT2A 1204/4885CYP1A2 75/4885CYP2C9 87/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.